https://www.selleckchem.com/products/GDC-0449.html
839-8.595; 0.001) were significant predictors of recurrence. Kaplan-Meier analysis showed no significant difference in DFS before or after propensity score matching ( =0.074 and =0.378, respectively . Intermediate-dose RAI ablation for the adjuvant treatment of DTC is sufficient as compared to high-dose RAI ablation. Further prospective or multicenter studies should be conducted to clarify the prognosis of intermediate-dose RAI ablation. Intermediate-dose RAI ablation for the adjuvant treatment of DTC is sufficient as compared to